Clinical outcome of renal cancer patients who early interrupted immunotherapy due to serious immune-related adverse events. Meet-Uro 13 trial on behalf of the MeetUro investigators.
J Transl Med
; 19(1): 328, 2021 08 03.
Article
in En
| MEDLINE
| ID: mdl-34344414
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Renal Cell
/
Kidney Neoplasms
Type of study:
Observational_studies
Limits:
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
J Transl Med
Year:
2021
Document type:
Article
Affiliation country:
Italy
Country of publication:
United kingdom